The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): a double-blind randomised placebo-controlled trial
<strong>Introduction</strong> The UK government stockpiles co-amoxiclav to treat bacterial complications during influenza pandemics. This pragmatic trial examines whether early co-amoxiclav use reduces re-consultation due to clinical deterioration in ‘at risk’ children presenting with i...
Autors principals: | Wang, K, Semple, MG, Moore, M, Tonner, S, Galal, U, Grabey, J, Carver, T, Perera, R, Yu, L-M, Mollison, J, Farmer, A, Butler, CC, Harnden, A, Et al. |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
European Respiratory Society
2021
|
Ítems similars
-
The early use of Antibiotics for At-risk children with InfluEnza in Primary Care (the ARCHIE programme)
per: Wang, K, et al.
Publicat: (2023) -
The early use of Antibiotics for At-risk children with InfluEnza in Primary Care (the ARCHIE programme)
per: Wang Kay, et al.
Publicat: (2023-05-01) -
Early use of Antibiotics for at Risk CHildren with InfluEnza (ARCHIE): protocol for a double-blind, randomised, placebo-controlled trial
per: Christopher Butler, et al.
Publicat: (2018-05-01) -
Early use of antibiotics for at risk children with influenza (ARCHIE): protocol for a double-blind, randomised, placebo-controlled trial
per: Wang, K, et al.
Publicat: (2018) -
Quality of life, healthcare use and costs in ‘at-risk’ children after early antibiotic treatment versus placebo for influenza-like illness: within-trial descriptive economic analyses of the ARCHIE randomised controlled trial
per: Paul Little, et al.
Publicat: (2022-04-01)